US stock · Healthcare sector · Drug Manufacturers—General
Company Logo

AbbVie Inc.

ABBVNYSE

143.06

USD
+0.05
(+0.03%)
Market Closed
20.23P/E
12Forward P/E
1.01P/E to S&P500
252.944BMarket CAP
3.87%Div Yield
Scale: |
View:
Currency: USD, in millions
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Income Statement
Revenue
14,214
15,638
17,444
18,380
18,790
19,960
22,859
25,638
28,216
32,753
33,266
45,804
56,197
COGS
4,056
4,293
4,639
4,508
4,581
4,426
4,500
5,833
7,040
7,718
7,439
15,387
17,446
Gross Profit
10,158
11,345
12,805
13,872
14,209
15,534
18,359
19,805
21,176
25,035
25,827
30,417
38,751
Gross Profit Ratio
71.46%
72.55%
73.40%
75.47%
75.62%
77.83%
80.31%
77.25%
75.05%
76.44%
77.64%
66.41%
68.96%
Operating Expenses
5,056
6,628
8,511
8,055
8,545
12,123
10,822
10,421
11,584
18,652
12,844
17,856
19,865
R&D Expenses
1,707
2,808
2,618
3,066
3,193
3,649
4,435
4,566
5,309
10,753
6,792
6,557
7,084
Selling, G&A Exp.
3,349
3,820
5,894
4,989
5,352
7,724
6,387
5,855
6,275
7,399
6,942
- -
12,349
General and Admin. Exp.
3,349
3,820
5,894
4,989
5,352
7,724
6,387
5,855
6,275
7,399
6,942
- -
- -
Selling and Marketing Exp.
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Expenses
- -
- -
- -
- -
- -
750
- -
- -
- -
500
(890)
11,299
432
COGS and Expenses
9,112
10,921
13,151
12,563
13,126
16,549
15,322
16,254
18,624
26,370
20,283
33,243
37,311
Interest Income
- -
28
- -
20
21
38
33
82
146
204
275
174
39
Interest Expense
- -
- -
- -
104
299
429
719
1,047
1,150
1,348
1,784
2,454
2,423
Depreciation and Amortization
697
1,184
1,272
1,150
897
786
836
1,189
1,501
1,765
2,017
6,471
8,521
EBITDA
6,648
6,020
4,941
6,979
6,528
3,584
8,200
10,120
10,378
8,310
12,227
12,317
23,926
EBITDA ratio
46.77%
38.50%
28.32%
37.97%
34.74%
17.96%
35.87%
39.47%
36.78%
25.37%
36.76%
26.89%
42.58%
Operating Income
4,932
4,717
3,621
5,817
5,664
3,411
7,537
9,384
9,592
6,383
12,983
11,363
17,924
Operating Income ratio
34.70%
30.16%
20.76%
31.65%
30.14%
17.09%
32.97%
36.60%
33.99%
19.49%
39.03%
24.81%
31.89%
Total Other Income Exp.(Gains)
1,019
119
48
(92)
(332)
(1,042)
(892)
(1,500)
(1,865)
(1,186)
(4,557)
(7,965)
(4,935)
Income Before Tax
5,950
4,836
3,669
5,725
5,332
2,369
6,645
7,884
7,727
5,197
8,426
3,398
12,989
Income Before Tax ratio
41.86%
30.92%
21.03%
31.15%
28.38%
11.87%
29.07%
30.75%
27.39%
15.87%
25.33%
7.42%
23.11%
Income Tax Expense (Gain)
1,314
658
235
450
1,204
595
1,501
1,931
2,418
(490)
544
(1,224)
1,440
Net Income
4,637
4,178
3,433
5,275
4,128
1,774
5,144
5,953
5,309
5,687
7,882
4,616
11,542
Net Income Ratio
32.62%
26.72%
19.68%
28.70%
21.97%
8.89%
22.50%
23.22%
18.82%
17.36%
23.69%
10.08%
20.54%
EPS
2.93
2.64
2.17
3.35
2.60
1.11
3.20
3.74
3.33
3.85
5.33
2.62
6.54
EPS Diluted
2.93
2.64
2.17
3.35
2.56
1.10
3.13
3.63
3.30
3.66
5.28
2.62
6.54
Weighted Avg. Shares Outs.
1,580
1,580
1,580
1,577
1,587
1,591
1,610
1,593
1,592
1,479
1,479
1,765
1,765
Weighted Avg. Shares Outs. Dil.
1,580
1,580
1,580
1,577
1,604
1,610
1,637
1,631
1,603
1,546
1,484
1,765
1,765
Balance Sheet
Cash and Cash Equivalents
- -
10
27
5,901
9,595
8,348
8,399
5,100
9,303
7,289
39,924
8,449
9,746
Short-Term Investments
- -
1
626
2,075
300
26
8
1,323
486
772
- -
30
84
Cash & Short-Term Investments
- -
11
654
7,976
9,895
8,374
8,407
6,423
9,789
8,061
39,924
8,479
9,830
Net Receivables
- -
3,373
3,817
4,298
4,803
4,291
4,730
4,758
5,088
5,384
5,428
8,822
9,977
Inventory
- -
836
872
1,091
1,150
1,124
1,719
1,444
1,605
1,605
1,813
3,310
3,128
Other Current Assets
- -
3,998
2,012
1,989
2,000
2,299
1,458
3,562
4,741
1,895
2,354
3,562
4,993
Total Current Assets
- -
8,218
7,354
15,354
17,848
16,088
16,314
16,187
21,223
16,945
49,519
24,173
27,928
PP&E
- -
2,358
2,144
2,247
2,298
2,485
2,565
2,604
2,803
2,883
2,962
5,248
5,110
Goodwill
- -
6,197
6,100
6,130
6,277
5,862
13,168
15,416
15,785
15,663
15,604
33,124
32,379
Intangible Assets
- -
3,691
2,910
2,323
1,890
1,513
19,709
28,897
27,559
21,233
18,649
82,876
75,951
Goodwill and Intangible Assets
- -
9,888
9,010
8,453
8,167
7,375
32,877
44,313
43,344
36,896
34,253
116,000
108,330
Investments
- -
137
229
119
118
92
145
1,783
2,090
1,420
93
293
277
Tax Assets
- -
533
920
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Non-Current Assets
- -
- -
- -
835
767
1,507
1,149
1,212
1,326
1,208
2,288
4,851
4,884
Total Non-Current Assets
- -
12,916
12,303
11,654
11,350
11,459
36,736
49,912
49,563
42,407
39,596
126,392
118,601
Other Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
- -
21,135
19,657
27,008
29,198
27,547
53,050
66,099
70,786
59,352
89,115
150,565
146,529
Accounts Payable
- -
357
417
556
933
881
1,597
1,407
1,474
1,546
1,452
2,276
2,882
Short-Term Debt
- -
- -
- -
1,042
431
4,446
2,431
402
6,415
5,308
3,753
8,502
12,495
Tax Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Current Liabilities
- -
3,404
5,480
5,178
5,515
6,073
6,866
7,972
8,752
10,385
10,380
17,883
19,817
Total Current Liabilities
- -
3,761
5,897
6,776
6,879
11,400
10,894
9,781
16,641
17,239
15,585
28,661
35,194
Long-Term Debt
- -
- -
- -
14,630
14,292
10,565
29,240
36,440
30,953
35,002
62,975
77,554
64,189
Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Deferred Tax Liabilities
- -
- -
- -
360
570
630
5,276
6,890
2,490
1,067
1,130
3,646
3,009
Other Non-Current Liabilities
- -
1,670
1,537
1,879
2,965
3,210
3,695
8,352
15,605
14,490
17,597
27,607
28,701
Total Non-Current Liabilities
- -
1,670
1,537
16,869
17,827
14,405
38,211
51,682
49,048
50,559
81,702
108,807
95,899
Other Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Lease Obligations
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Liabilities
- -
5,432
7,433
23,645
24,706
25,805
49,105
61,463
65,689
67,798
97,287
137,468
131,093
Preferred Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Common Stock
- -
- -
- -
3,713
16
16
17
18
18
18
18
18
18
Retained Earnings
- -
- -
- -
- -
1,567
535
2,248
4,378
5,459
3,368
4,717
1,055
3,127
Other Compreh. Income(Loss)
- -
288
(25)
(350)
(442)
(2,031)
(2,561)
(2,586)
(2,727)
(2,480)
(3,596)
(3,117)
(2,899)
Other Total Stockhold. Equity
- -
15,415
12,249
- -
3,351
3,222
4,241
2,826
2,347
(9,352)
(9,311)
15,120
- -
Total Stockholders Equity
- -
15,703
12,224
3,363
4,492
1,742
3,945
4,636
5,097
(8,446)
(8,172)
13,076
15,408
Total Liab.&Stockhold. Equity
- -
21,135
19,657
27,008
29,198
27,547
53,050
66,099
70,786
59,352
89,115
150,544
146,501
Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
21
28
Total Liabilities & Equity
- -
21,135
19,657
27,008
29,198
27,547
53,050
66,099
70,786
59,352
89,115
150,565
146,529
Cash Flow Statement
Net Income
4,637
4,178
3,433
5,275
4,128
1,774
5,144
5,953
5,309
5,687
7,882
4,616
11,542
Depreciation and Amortization
697
1,184
1,272
1,150
897
786
836
1,189
1,501
1,765
2,017
6,471
8,521
Deferred Income Tax
- -
- -
- -
- -
- -
- -
- -
- -
1,242
424
- -
(2,325)
(898)
Stock Based Compensation
157
167
163
187
212
241
282
353
365
421
430
753
692
Change in Working Capital
504
(866)
706
(621)
658
(788)
504
(1,689)
9
(1,126)
(1,329)
106
(1,322)
Accounts Receivable
(322)
(60)
(498)
223
- -
- -
- -
(71)
(391)
(591)
(74)
(929)
(1,321)
Inventory
165
(73)
(88)
(203)
(56)
(203)
(434)
(38)
93
(226)
(231)
(40)
(142)
Accounts Payable
210
(695)
1,497
(731)
(426)
(193)
1,503
(1,187)
425
190
(1,121)
1,514
1,628
Other Working Capital
- -
4,457
1,457
8,578
10,969
4,688
5,420
6,406
4,582
(294)
33,934
(573)
(1,290)
Other Non-Cash Items
(627)
313
673
354
372
1,536
769
1,235
1,534
6,256
4,324
7,967
4,242
Cash Provided by Operating Activities
5,367
4,976
6,247
6,345
6,267
3,549
7,535
7,041
9,960
13,427
13,324
17,588
22,777
CAPEX
(313)
(448)
(356)
(333)
(491)
(612)
(532)
(479)
(529)
(638)
(552)
(798)
(787)
Acquisitions Net
(170)
(2,621)
(273)
(688)
(405)
(622)
(12,452)
(2,757)
(308)
(736)
(1,135)
(39,610)
(1,902)
Purchases of Investments
(4)
(93)
(1,943)
(2,550)
(930)
(1,169)
(851)
(5,315)
(2,230)
(1,792)
(583)
(61)
(119)
Sales/Maturities of Investments
0
1
1,255
1,153
2,705
1,477
880
2,359
2,793
2,160
2,699
1,525
98
Other Investing Activities
0
(1,870)
1,870
- -
- -
- -
19
118
- -
- -
167
1,387
366
Cash Used for Investing Activities
(486)
(5,031)
554
(2,418)
879
(926)
(12,936)
(6,074)
(274)
(1,006)
596
(37,557)
(2,344)
Debt Repayment
(35)
- -
(21)
- -
- -
- -
(4,018)
(6,010)
(25)
(6,035)
(5,235)
(5,683)
(9,414)
Common Stock Issued
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Common Stock Repurchased
- -
- -
- -
- -
(320)
(652)
(7,567)
(6,033)
(1,410)
(12,014)
(629)
(978)
(934)
Dividends Paid
- -
- -
- -
- -
(2,555)
(2,661)
(3,294)
(3,717)
(4,107)
(5,580)
(6,366)
(7,716)
(9,261)
Other Financing Activities
(4,846)
65
(6,762)
1,931
(567)
20
20,631
11,832
30
9,233
30,938
2,876
570
Cash Used/Provided by Financing Activities
(4,881)
65
(6,783)
1,931
(3,442)
(3,293)
5,752
(3,928)
(5,512)
(14,396)
18,708
(11,501)
(19,039)
Effect of Forex Changes on Cash
- -
- -
- -
16
(10)
(577)
(300)
(338)
29
(39)
7
(5)
(97)
Net Change In Cash
(0)
65
18
5,874
3,694
(1,247)
51
(3,299)
4,203
(2,014)
32,635
(31,475)
1,297
Cash at the End of Period
0
10
27
5,901
9,595
8,348
8,399
5,100
9,303
7,289
39,924
8,449
9,746
Cash at the Beginning of Period
0
- -
10
27
5,901
9,595
8,348
8,399
5,100
9,303
7,289
39,924
8,449
Free Cash Flow
5,055
4,528
5,891
6,012
5,776
2,937
7,003
6,562
9,431
12,789
12,772
16,790
21,990
Forex Rate
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -